Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of ex Vivo Drug Combination Optimization Platform in Recurrent High Grade Astrocytic Glioma

NCT05532397 is registered in ClinicalTrials.gov with National University Hospital, Singapore as lead sponsor.

NCT NCT05532397
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05532397 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of ex Vivo Drug Combination Optimization Platform in Recurrent High Grade Astrocytic Glioma
Lead sponsor
National University Hospital, Singapore
Phase
Not applicable
Overall status
Recruiting
Start date
February 17, 2023
Completion date
December 31, 2026
Enrollment
10 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

glioma, astrocytic